Skeletal Muscle Measurements in Pediatric Hematology and Oncology: Essential Components to a Comprehensive Assessment

Area of Science:

• Pediatric Health
• Neuromuscular Physiology
• Rehabilitation Science

Background:

• Children with hematologic and oncologic conditions face risks of impaired skeletal muscle strength, size, and neuromuscular activation.
• These impairments can significantly limit gross motor performance in affected children.
• Early and accurate assessment is crucial for managing these conditions.

Purpose of the Study:

• To review the fundamental properties of skeletal muscle.
• To outline methods for quantifying muscle strength, size, and neuromuscular activation.
• To recommend clinical assessment strategies for pediatric patients with hematologic and oncologic conditions.

Main Methods:

• Literature review focusing on skeletal muscle physiology and assessment techniques.
• Synthesis of current knowledge on neuromuscular function in pediatric populations.
• Analysis of clinical assessment measures relevant to muscle function.

Main Results:

• Skeletal muscle properties and their contribution to motor performance are detailed.
• Methods for assessing muscle strength, size, and neuromuscular activation are presented.
• Clinical assessment measures and examples (sickle cell disease, musculoskeletal sarcoma) are illustrated.

Conclusions:

• Comprehensive neuromuscular assessment is essential for children with hematologic/oncologic conditions.
• This assessment aids in identifying muscle changes and monitoring therapeutic exercise impact.
• Evidence-based recommendations for clinical practice are provided.